VIRTRIS is a health data pioneer based in Seoul, South Korea, specializing in health data integration and analysis with the goal to accelerate drug discovery and approval.

VIRTRIS

Unlearn is a company focused on AI-powered clinical trials, utilizing digital twins of patients to design more efficient, ethical, and reliable clinical studies. They aim to improve treatment comparisons and personalized treatment plans using AI, with the goal of scaling these solutions to turn most of medicine into a computational science.

Aaron Smith

Charles Fisher

Jonathan Walsh

Unlearn

Square Pharmaceuticals PLC is engaged in the manufacturing and marketing of pharmaceutical products, herbal and nutraceutical products, and agrovet and crop care products.

Square Pharmaceuticals PLC

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

S Nikhil Kumar

AbbVie Inc.

VIRTRIS is a health data pioneer based in Seoul, South Korea, specializing in health data integration and analysis with the goal to accelerate drug discovery and approval. self-described.

Virtus | 2,388 followers on LinkedIn. Push forward—we’ve got your back. | Virtus is an insurance brokerage and consulting firm built for today’s experience economy. We blend creativity with technology to bring a more streamlined, personalized and human approach to insurance. This insulates our clients from the process, putting the focus back on their goals and growth strategy to unlock their full potential.

Operations Leadership | Insurance Professional | Strategic Initiatives | Project Management | Data Analytics | Process Optimization |

Tamara Huyck, CPCU, FLMI, MBA

Managing Partner at Virtus, LLC

Michael Kesner

Account Manager II

STEPHANIE CRANDALL, CISR

Director of Surety at Virtus

Karra McGreevy

Virtus

After a remarkable 41-year career in insurance, including 25 years with Kemmons Wilson Insurance Group (now part of Virtus), our esteemed partner, Cindy Klatt, is retiring. Read the full announcement here: https://lnkd.in/gwCdWYk9 #EmployeeAppreciation , #TeamRecognition , #YouRock , #TeamworkMakesTheDreamWork , #GratefulForYou , #InGoodCompany , #YouNailedIt , #Thanks , #TeamGoals #retirement Cindy H. Klatt, CIC, CRM, CWCA

As the holiday season approaches, cold weather becomes a significant concern for the hospitality industry, particularly for hotels, resorts, and restaurants in regions prone to freezing conditions, including places like Texas, which has experienced substantial freeze claims. Slip, trip, and fall incidents due to snow and ice are common, posing risks to both staff and guests. To mitigate these potential losses, it’s essential to have external contracts in place for snow and ice remediation and to ensure these measures are shored up well in advance. Beyond personal injury risks, the threat of freezing pipes or other weather-related property damage is also a major concern. Hotels and resorts, especially those with high vacancy rates, need to implement proactive measures to prevent such losses. This includes regular inspections of unoccupied rooms or areas, documentation of these checks, and a clear action plan to address any vulnerabilities. Working closely with the Kemmons Wilson Hospitality Practice at Virtus can help you establish a comprehensive loss prevention strategy, ensuring that any foreseeable damage is mitigated, and costly claims are avoided so you can focus on what matters most this holiday season: the guest experience. #hospitality #personalinjury #propertydamage #insurance

Middle market deal activity has shown remarkable resilience, with a significant rebound observed in 2023 and 2024. This uptick can be attributed to a convergence of factors: sellers who had been holding off are now eager to sell, and there’s an abundance of capital ("dry powder") in private equity seeking investment opportunities. This has led to increased deal volume, especially in the middle market, where many businesses are still founder-owned. These companies often find themselves at a pivotal moment, seeking institutional capital for the first time as founders look to monetize the businesses they've built over years or even decades. #middlemarketdeals #midmarketMandA #corporatefinance #mergersandacquisitions #privateequity #investmentbanking #dealflow #businessacquisition #growthstrategy #strategicalliances #exitstrategy #MandAadvisor #transactional #smallbusinessdeals #midsizebusiness

What an incredible day last week at the Virtus Open House! 🎉 We had an amazing turnout filled with putt-putt fun, networking, and most importantly, a shared passion for supporting our community. We are thrilled to announce that, thanks to the overwhelming support of our attendees and sponsors, we raised $25,000 for the Rose Brooks Center Inc. ! 🌹 ✨ The funds will go a long way in helping provide safety and support for those in need. Our private auction was a highlight of the day, with participants enthusiastically bidding on exclusive items, making it a huge success! We couldn't be more grateful for the generosity and spirit of everyone who joined us. A huge thank you to all who attended, our amazing team, and our dedicated sponsors who made this event possible. We’re proud to have such a supportive community around us, and we can’t wait to continue working together to make a positive impact. 🙏 Looking forward to more moments like this! 💙 #EventRecap #CommunitySupport #CharitableGiving #Networking #VirtusEvents RT Specialty Amwins IPFS Cigna Healthcare Ansel Health Aetna, a CVS Health Company Waypoint Mutual Travelers Jencap Arch Insurance Group Inc. UnitedHealthcare intellicents

We believe that leadership is more than just strategy—it’s about building a culture where self-starters and entrepreneurs thrive. Our recent quarterly leadership strategy session took an exciting turn as we hit the CSU football field, bringing the same energy and drive we put into our work onto the field. This hands-on approach reflects our commitment to growth, teamwork, and a fearless pursuit of a "Better Tomorrow," both in business and beyond. It’s these moments that strengthen our core values and remind us why we’re so passionate about cultivating a dynamic company culture. #Culture #EntrepreneurialSpirit #LeadershipInAction

It’s auction time! Look forward to seeing everyone at our Open House soon ⛳️✨ cc Rose Brooks Center Inc.

Thank you, Virtus . The kindness of you and your networks today at your putt-putt and networking event was nothing short of remarkable. Please know that you have made a difference in the lives of survivors of domestic violence. You have given the gift of safety... and what a difference safety makes for those we serve! We thank you. . Lisa Fleming , Rose Brooks Center's CEO shared a few words about the impact of your kindness and was able to receive your gift on Rose Brooks Center's behalf. . #Survivors of #DomesticViolence #Kindness #SafeFutures #WhatADifferenceSafetyMakes

Rose Brooks Center Inc.

As we transition from the summer travel season into the planning phase for 2025, it's critical for businesses to prepare for their total cost of risk. At this time, our focus is not solely on premium spend but on the broader spectrum of risk management, ensuring that clients have a holistic view of their financial exposure. Understanding the total cost of risk, including premiums, workers' compensation, payroll exposures, and ownership liabilities, helps businesses strategically navigate the upcoming year. This approach ensures that insurance serves as a tool for success, rather than a hindrance, in managing risk and operational costs. Given the constant changes in the industry, particularly with legislative shifts, we are closely monitoring how these changes will impact both employee costs and liability exposures. In the property insurance marketplace, we’re seeing stabilization after years of continuous rate increases. While rates aren't softening, the market has gained a level of efficiency, potentially leading to better pricing opportunities. Our goal remains to pull every lever available to optimize cost savings, ensuring that clients are armed with all necessary insights to stay ahead of market shifts and maximize value. #insurance #riskmanagement #hospitality

Our Open House is THIS Wednesday! ⛳ Join us for an afternoon of putt-putt and networking while we raise money for the amazing Rose Brooks Center Inc. ... all before it's time to cheer on our boys in blue 💙 12:30-4:30 p.m. at Craft Putt in Overland Park; RSVP and view event details here: https://lnkd.in/gfaXMGqY We'll see you there! #networking #fundraising

Say "Hello!" and come meet our Kemmons Wilson Hospitality Team at The Lodging Conference !

Metric
Company Name	VIRTRIS	Unlearn	Square Pharmaceuticals PLC	AbbVie Inc.
Symbol				ABBV
MSH ID	COM:VIRTRIS	AI:UNLEARN	BD:COM:SQUAREPHARMA	COM:ABBVIE
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Technology and Medicine	Healthcare & Health Services	Healthcare
Industry	Biotechnology	Healthcare and Artificial Intelligence	Pharmaceuticals	Drug Manufacturers - General
Country	KR	US	BD	US
Stage		Series C
Employee Count		84		50K
Website	virtris.com	unlearn.ai	squarepharma.com.bd	abbvie.com
LinkedIn	virtus	unlearn-ai
Founders

Metric
Market Cap	180M	296.91B
Enterprise Value
Monthly Web Traffic	3.97K	1.18M
Web Traffic Growth	0.53	0.51
Valuation
Raised Capital	50M	15B

Metric
Revenue				54.32B
Revenue (LTM)
Revenue (NTM)
Gross Profit				45.54B
EBITDA				18.10B
Operating Income				17.43B
Net Income				4.86B
EPS				2.75
Diluted EPS				2.74
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.72
Operating Profit Margin				0.27
EBITDA Margin				0.33
Net Profit Margin				0.11
Return on Equity				0.57
Return on Assets				0.04
Return on Capital Employed				0.15

VIRT

COM:VIRTRIS

VIRTRIS

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				46.58
P/B Ratio				25.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				6.36
EV Multiple				17.44

Metric
Days Sales Outstanding				75.54
Days Payables Outstanding
Days Inventory Outstanding				102.41
Operating Cycle				181.71
Cash Conversion Cycle				179.57
Asset Turnover				0.40

Metric
Operating Cash Flow				22.84B
Free Cash Flow				22.06B
Cash Flow to Debt				0.38
Operating Cash Flow/Sales				0.42
Free Cash Flow Yield				0.08

Metric
Cash & Equivalents				12.81B
Accounts Receivable				66M
Inventory				4.10B
Goodwill				32.29B
Debt to Capitalization				0.91
Debt to Assets				0.45
Current Ratio				0.96
Quick Ratio				0.83

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue				0.14
SG&A to Revenue